Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 7
122
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Exploration of therapeutic role of montelukast and dexamethasone combination against paraquat induced inhalational toxicity

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 299-310 | Received 01 Jan 2020, Accepted 14 Jun 2020, Published online: 28 Jun 2020

References

  • Ahmed A. 2009. Protective effect of montelukast on paraquat-induced lung toxicity in rats. Biosci Trends. 3:63–72.
  • Amirshahrokhi K, Khalili AR. 2016. Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-κB activation and oxidative stress mediators. Cytokine. 88:144–153.
  • Benjamin B. 2019. Overview of laboratory animal lifestyle, care, and management: a case study of albino rats. J Appl Sci Environ Manag. 23:1431.
  • Bentli R, Ciftci O, Cetin A, Otlu A. 2016. Anti-inflammatory montelukast prevents toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin: oxidative stress, histological alterations in liver, and serum cytokine levels. Toxicol Ind Health. 32:769–776.
  • Chen GH, Lin JL, Huang YK. 2002. Combined methylprednisolone and dexamethasone therapy for paraquat poisoning. Crit Care Med. 30:2584–2587.
  • Chen T, Wang R, Jiang W, Wang H, Xu A, Lu G, Ren Y, Xu Y, Song Y, Yong S, et al. 2016. Protective effect of astragaloside IV against paraquat-induced lung injury in mice by suppressing rho signaling. Inflammation. 39:483–492.
  • Delirrad M, Majidi M, Boushehri B. 2015. Clinical features and prognosis of paraquat poisoning: a review of 41 cases. Int J Clin Exp Med. 8:8122–8128.
  • Dezube R. 2019. Overview of the respiratory system. MSD manuals. Kenilworth, NJ: Merck and Co.
  • Dinis-Oliveira RJ, Duarte JA, Remião F, Sánchez-Navarro A, Bastos ML, Carvalho F. 2006. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology. 227:73–85.
  • Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. 2008. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol. 38:13–71.
  • Dinis-Oliveira RJ, Remião F, Duarte JA, Ferreira R, Sánchez Navarro A, Bastos ML, Carvalho F. 2006. P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity. Free Radic Biol Med. 41:1213–1224.
  • Dinis-Oliveira RJ, Sarmento A, Reis P, Amaro A, Remião F, Bastos ML, Carvalho F. 2006. Acute paraquat poisoning: report of a survival case following intake of a potential lethal dose. Pediatr Emerg Care. 22:537–540.
  • Dinis-Oliveira RJ, Valle M, Bastos ML, Carvalho F, Sánchez Navarro A. 2006. Kinetics of paraquat in the isolated rat lung: Influence of sodium depletion. Xenobiotica. 36:724–737.
  • Hou H, Li B, Zhao X, Zhuang Y, Ren G, Yan M, Cai Y, Zhang X, Chen L. 2009. The effect of pacific cod (Gadus macrocephalus) skin gelatin polypeptides on UV radiation-induced skin photoaging in ICR mice. Food Chem. 115:945–950.
  • Hu X, Shen H, Wang Y, Zhao M. 2017. Liver X receptor agonist TO901317 attenuates paraquat-induced acute lung injury through inhibition of NF- κ B and JNK/p38 MAPK signal pathways. Biomed Res Int. 2017:4652695.
  • Kavousi-Gharbi S, Jalli R, Rasekhi-Kazerouni A, Habibagahi Z, Marashi SM. 2017. Discernment scheme for paraquat poisoning: a five-year experience in Shiraz. WJEM. 7:31–39.
  • Kumar H, Singh VB, Meena BL, Gaur S, Singla R. 2016. Paraquat poisoning: a case report. J Clin Diagnostic Res. 10:OD10–OD11.
  • Lan C, Wang J, Li L, Li H, Li L, Su Q, Che L, Liu L, Di M. 2015. Effects of different tidal volume ventilation on paraquat-induced acute lung injury in piglets. Med Sci Monit. 21:452–458.
  • Liu M, Su M, Zhang W, Wang Y, Chen M, Wang L, Qian C. 2014. Protective effect of Xuebijing injection on paraquat-induced pulmonary injury via down-regulating the expression of p38 MAPK in rats. BMC Complement Altern Med. 14:498.
  • Luan RL, Meng XX, Jiang W. 2016. Protective effects of apigenin against paraquat-induced acute lung injury in mice. Inflammation. 39:752–758.
  • Luo S, Pauluhn J, Trübel H, Wang C. 2014. Corticosteroids found ineffective for phosgene-induced acute lung injury in rats. Toxicol Lett. 229:85–92.
  • Mandal S, Pathak MP, Sharma Bora N, Patowary P, Barman PK, Kishor S, Goyary D, Verma N, Chattopadhyay P. 2019. Determination of LCt50 of aerosolized paraquat and its pulmonary toxic implications in non-anesthetized rats. Drug Chem Toxicol. 42:552–558.
  • Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, Torky ME, Leeper KV. 1991. Fibroproliferative Phase of ARDS. Clinical findings and effects of corticosteroidsChest. 100:943–952.
  • Mohamadin AM, Elberry AA, Elkablawy MA, Gawad H, Al-Abbasi FA. 2011. Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology. 18:235–242.
  • [OECD] Organisation for Economic Cooperation and Development. 2009a. Test No. 403: Acute inhalation toxicity. OECD Guidelines for the Testing of Chemicals, Section 4.
  • [OECD] Organisation for Economic Cooperation and Development. 2009b. Test No. 436: Acute inhalation toxicity – acute toxic class method. OECD Guidelines for the Testing of Chemicals, Section 4.
  • [OECD] Organisation for Economic Cooperation and Development. 2016. Test No. 421: Reproduction/developmental toxicity screening test. OECD Guidelines for the Testing of Chemicals, Section 4.
  • Paraquat Technical Data. 2018. Switzerland: Paraquat Inf Center, Syngenta Crop Prot AG. [accessed 2018 Mar 2]. http://paraquat.com/en/facts/paraquat-technical-data
  • Pasricha JS, Seetharam KA, Das U. 1989. Further studies on pemphigus patients treated with dexamethasone. Indian J Dermatol Venereol Leprol. 55:98–104.
  • Purohit A, Kopferschmitt-Kubler MC, Moreau C, Popin E, Blaumeiser M, Pauli G. 2000. Quaternary ammonium compounds and occupational asthma. Int Arch Occup Environ Health. 73:423–427.
  • Reiss TF, Hill JB, Harman E, Zhang J, Tanaka WK, Bronsky E, Guerreiro D, Hendeles L. 1997. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax. 52:1030–1035.
  • Rocco PRM, Souza AB, Faffe DS, Pássaro CP, Santos FB, Negri EM, Lima JGM, Contador RS, Capelozzi VL, Zin WA. 2003. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med. 168:677–684.
  • Rumsey WLL, Bolognese B, Davis ABB, Flamberg PLL, Foley JPP, Katchur SRR, Kotzer CJJ, Osborn RRR, Podolin P. 2017. Effects of airborne toxicants on pulmonary function and mitochondrial DNA damage in rodent lungs. Mutagenesis [Internet]. 32:343–353.
  • Said MM, Bosland MC. 2017. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate. Naunyn Schmiedebergs Arch Pharmacol. 390:197–205.
  • Shao X, Li M, Luo C, Wang YY, Lu Y, Feng S, Li H, Lang X, Wang YY, Lin C, et al. 2015. Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice. J Zhejiang Univ Sci B. 16:52–61.
  • Sun Y, Zhang J, Yan Y, Chi M, Chen W, Sun P, Qin S. 2011. The protective effect of C-phycocyanin on paraquat-induced acute lung injury in rats. Environ Toxicol Pharmacol. 32:168–174.
  • Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, Ishii H, Ota T, Nishikawa T, Kawai Y, et al. 2000. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem Biophys Res Commun. 274:316–322.
  • Tsai W. 2013. A review on environmental exposure and health risks of herbicide paraquat. Toxicol Environ Chem. 95:197–206.
  • Tuğtepe H, Şener G, Çetinel Ş, Velioğlu-Öğünç A, Yeğen BÇ. 2007. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Eur J Pharmacol. 557:69–75.
  • Verheijden KAT, Henricks PAJ, Redegeld FA, Garssen J, Folkerts G. 2014. Measurement of airway function using invasive and non-invasive methods in mild and severe models for allergic airway inflammation in mice. Front Pharmacol. 5:190.
  • Wallace JL, MacNaughton WK, Morris GP, Beck PL. 1989. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 96:29–36.
  • Wang X, Luo F, Zhao H. 2014. Paraquat-induced reactive oxygen species inhibit neutrophil apoptosis via a p38 MAPK/NF-κB-IL-6/TNF-α positive-feedback circuit. PLoS One. 9:e93837.
  • Watts M. 2011. Paraquat. Penang (Malaysia).
  • Williams JD, Czop JK, Austen KF. 1984. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 132:3034–3040.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.